Susan L. Garson

2.3k citations

19 papers · 850 indexed · h-index 15

Endocrine and Autonomic Systems top 1%
- Circadian rhythm and melatonin 14
- Regulation of Appetite and Obesity 3
Experimental and Cognitive Psychology top 2%
- Sleep and related disorders 14
Cognitive Neuroscience top 2%
- Sleep and Wakefulness Research 16
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 2
Sensory Systems
Materials Chemistry
- Photochromic and Fluorescence Chemistry 2
Molecular Biology
- Receptor Mechanisms and Signaling 1
Pharmacology
- Cholinesterase and Neurodegenerative Diseases 1

Co-authors: John J. Renger Anthony L. Gotter Christopher J. Winrow Paul J. Coleman Steven V. Fox Pamela L. Tannenbaum Joanne Stevens C. Meacham Harrell
Cited by: Endocrine and Autonomic Systems Experimental and Cognitive Psychology Cognitive Neuroscience
Partner nations: United States Japan China

In The Last Decade

Susan L. Garson

19 papers receiving 828 citations

Peers

Countries citing papers authored by Susan L. Garson

Since Specialization

Citations

This map shows the geographic impact of Susan L. Garson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Garson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Garson more than expected).

Fields of papers citing papers by Susan L. Garson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Garson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Garson. The network helps show where Susan L. Garson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan L. Garson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan L. Garson Line = papers co-authored together Susan L. Garson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man Anthony L. Gotter,Mark S. Forman,C. Meacham Harrell,Joanne Stevens,Vladimir Svetnik,Ka Lai Yee,Xiaodong Li,Anthony J. Roecker,Steven V. Fox,Pamela L. Tannenbaum,Susan L. Garson,Inge De Lepeleire,Nicole Calder,Laura Rosen,Arie Struyk,Paul J. Coleman,W. Joseph Herring,John J. Renger,Christopher J. Winrow	2016	67
2	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements Anthony J. Roecker,Swati P. Mercer,Jeffrey M. Bergman,Kevin F. Gilbert,Scott D. Kuduk,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Pamela L. Tannenbaum,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	2015	14
3	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties Scott D. Kuduk,Jason W. Skudlarek,Christina N. DiMarco,Joseph G. Bruno,Mark H. Pausch,Julie A. O’Brien,Tamara D. Cabalu,Joanne Stevens,Joseph Brunner,Pamela L. Tannenbaum,Susan L. Garson,Alan T. Savitz,C. Meacham Harrell,Anthony L. Gotter,Christopher J. Winrow,John J. Renger,Paul J. Coleman	2015	15
4	Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators Anthony L. Gotter,Susan L. Garson,Joanne Stevens,Regina Lynn Munden,Steven V. Fox,Pamela L. Tannenbaum,Lihang Yao,Scott D. Kuduk,Terrence McDonald,Jason M. Uslaner,Spencer J. Tye,Paul J. Coleman,Christopher J. Winrow,John J. Renger	2014	40
5	Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs Pamela L. Tannenbaum,Joanne Stevens,Jacquelyn Binns,Alan T. Savitz,Susan L. Garson,Steven V. Fox,Paul J. Coleman,Scott D. Kuduk,Anthony L. Gotter,Michael J. Marino,Spencer J. Tye,Jason M. Uslaner,Christopher J. Winrow,John J. Renger	2014	32
6	Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis Anthony J. Roecker,Swati P. Mercer,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	2014	9
7	Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant Izzat T. Raheem,Michael J. Breslin,Joseph G. Bruno,Tamara D. Cabalu,Andrew Cooke,Christopher D. Cox,Donghui Cui,Susan L. Garson,Anthony L. Gotter,Steven V. Fox,C. Meacham Harrell,Scott D. Kuduk,Wei Lemaire,Thomayant Prueksaritanont,John J. Renger,Craig A. Stump,Pamela L. Tannenbaum,Peter D. Williams,Christopher J. Winrow,Paul J. Coleman	2014	17
8	Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats Steven V. Fox,Anthony L. Gotter,Spencer J. Tye,Susan L. Garson,Alan T. Savitz,Jason M. Uslaner,Joseph I. Brunner,Pamela L. Tannenbaum,Terrence P. McDonald,Robert A. Hodgson,Lihang Yao,Mark R. Bowlby,Scott D. Kuduk,Paul J. Coleman,Richard Hargreaves,Christopher J. Winrow,John J. Renger	2013	33
9	The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold Anthony L. Gotter,Christopher J. Winrow,Joseph Brunner,Susan L. Garson,Steven V. Fox,Jacquelyn Binns,C. Meacham Harrell,Donghui Cui,Ka Lai Yee,Mark Stiteler,Joanne Stevens,Alan T. Savitz,Pamela L. Tannenbaum,Spencer J. Tye,Terrence P. McDonald,Leon Yao,Scott D. Kuduk,Jason M. Uslaner,Paul J. Coleman,John J. Renger	2013	76
10	Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators Andres D. Ramirez,Anthony L. Gotter,Steven V. Fox,Pamela L. Tannenbaum,Lihang Yao,Spencer J. Tye,Terrence P. McDonald,Joseph Brunner,Susan L. Garson,Duane R. Reiss,Scott D. Kuduk,Paul J. Coleman,Jason M. Uslaner,Robert A. Hodgson,Susan Browne,John J. Renger,Christopher J. Winrow	2013	33
11	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) Swati P. Mercer,Anthony J. Roecker,Susan L. Garson,Duane R. Reiss,C. Meacham Harrell,Kathy Murphy,Joseph G. Bruno,Rodney A. Bednar,Wei Lemaire,Donghui Cui,Tamara D. Cabalu,Cuyue Tang,Thomayant Prueksaritanont,George D. Hartman,Steven D. Young,Christopher J. Winrow,John J. Renger,Paul J. Coleman	2013	19
12	Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia Christopher J. Winrow,Anthony L. Gotter,Christopher D. Cox,Pamela L. Tannenbaum,Susan L. Garson,Scott M. Doran,Michael J. Breslin,John D. Schreier,Steven V. Fox,C. Meacham Harrell,Joanne Stevens,Duane R. Reiss,Donghui Cui,Paul J. Coleman,John J. Renger	2011	109
13	Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross Joseph I. Brunner,Anthony L. Gotter,Joshua Millstein,Susan L. Garson,Jacquelyn Binns,Steven V. Fox,Alan T. Savitz,He S. Yang,Karrie Fitzpatrick,Lili Zhou,Joseph R. Owens,Andrea L. Webber,Martha Hotz Vitaterna,Andrew Kasarskis,Victor N. Uebele,Fred W. Turek,John J. Renger,Christopher J. Winrow	2011	7
14	Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist Christopher J. Winrow,Anthony L. Gotter,Christopher D. Cox,Scott M. Doran,Pamela L. Tannenbaum,Michael J. Breslin,Susan L. Garson,Steven V. Fox,C. Meacham Harrell,Joanne Stevens,Duane R. Reiss,Donghui Cui,Paul J. Coleman,John J. Renger	2011	218
15	Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat Paul J. Coleman,John D. Schreier,Anthony J. Roecker,Swati P. Mercer,Georgia B. McGaughey,Christopher D. Cox,George D. Hartman,C. Meacham Harrell,Duane R. Reiss,Scott M. Doran,Susan L. Garson,Wayne B. Anderson,Cuyue Tang,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger	2010	21
16	Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice Victor N. Uebele,Anthony L. Gotter,Cindy E. Nuss,Richard L. Kraus,Scott M. Doran,Susan L. Garson,Duane R. Reiss,Yuxing Li,James C. Barrow,Thomas S. Reger,Zhi-Qiang Yang,Jeanine Ballard,Cuyue Tang,Joseph M. Metzger,Sheng-Ping Wang,Kenneth S. Koblan,John J. Renger	2009	61
17	Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure Christopher J. Winrow,Keith Q. Tanis,Duane R. Reiss,Alison Rigby,Jason M. Uslaner,Victor N. Uebele,Scott M. Doran,Steven V. Fox,Susan L. Garson,Anthony L. Gotter,David Levine,Anthony J. Roecker,Paul J. Coleman,Kenneth S. Koblan,John J. Renger	2009	61
18	T-type calcium channels regulate cortical plasticity in-vivo NR-D-08-7049 Victor N. Uebele,Cindy E. Nuss,Vincent P. Santarelli,Susan L. Garson,James C. Barrow,Shaun R. Stauffer,Kenneth S. Koblan,John J. Renger,Sara J. Aton,Julie Seibt,Michelle Dumoulin,Sushil K. Jha,Tammi Coleman,Marcos G. Frank	2009	15
19	P4‐332: In vivo pharmacodynamic effects of BQCA, a novel selective allosteric M1 receptor modulator Marion Wittmann,Guangping Xu,Michelle Pearson,Susan L. Garson,Scott M. Doran,John J. Renger,Andrew Danziger,Christopher P. Regan,Guy R. Seabrook,William J. Ray	2008	3

About Susan L. Garson

Susan L. Garson is a scholar working on Endocrine and Autonomic Systems, Experimental and Cognitive Psychology and Cognitive Neuroscience, having authored 19 papers that have together received 850 indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (16 papers), Sleep and related disorders (14 papers), Circadian rhythm and melatonin (14 papers), Regulation of Appetite and Obesity (3 papers), Photochromic and Fluorescence Chemistry (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Receptor Mechanisms and Signaling (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (593 citations), Experimental and Cognitive Psychology (602 citations) and Cognitive Neuroscience (703 citations). Susan L. Garson has collaborated with scholars based in United States, Japan and China. Frequent co-authors include John J. Renger, Anthony L. Gotter, Christopher J. Winrow, Paul J. Coleman, Steven V. Fox, Pamela L. Tannenbaum, Joanne Stevens, C. Meacham Harrell, Duane R. Reiss and Scott M. Doran.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact